{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:43:55Z","timestamp":1781063035251,"version":"3.54.1"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T00:00:00Z","timestamp":1182816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:\u2002<\/jats:bold>\n                    To study the associations between weight loss with sibutramine and orlistat with psychological aspects that may interact with patients\u2019 response to these drugs.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    A total of 478 obese patients with a mean body mass index of 42 \u00b1 12 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    gave self\u2010reported, retrospective data on different types of previous weight loss treatments (sibutramine and orlistat, and Weight Watchers used as a control condition) including the amount of weight lost with these treatments, eating behaviour (Dutch Eating Behaviour Questionnaire) and personality (NEO Personality Inventory \u2013 Revised).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    Greater weight loss with sibutramine was associated with lower levels of restrained eating and higher levels of \u2018neuroticism\u2019, in particular \u2018anxiety\u2019 and \u2018depression\u2019. Greater weight loss with orlistat was associated with aspects of the personality dimension \u2018conscientiousness\u2019 (e.g. \u2018order\u2019 and \u2018deliberation\u2019).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:\u2002<\/jats:bold>\n                    Sibutramine may exert its greatest effect in patients whose eating is a \u2018natural\u2019 response to hunger rather than regulated by cognitions and conscious controls. Patients with low levels of restraint could be more sensitive to the satiety\u2010enhancing effect of sibutramine. They may be able to reduce their food intake without cognitive interference and\/or start to control their eating most radically in response to enhanced satiety. Enhanced satiety may also help patients withstand a wish to eat triggered by psychological distress. Possible central nervous system effects on mood could also have reduced eating, which was related to distress. The administration regimen of orlistat is more demanding, requiring greater adherence. This can account for the finding that personality attributes such as conscientiousness are important for success.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2007.00740.x","type":"journal-article","created":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T04:21:56Z","timestamp":1182831716000},"page":"498-505","source":"Crossref","is-referenced-by-count":22,"title":["Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success"],"prefix":"10.1111","volume":"10","author":[{"given":"K.","family":"Elfhag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Finer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"R\u00f6ssner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,26]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"S18","article-title":"Sibutramine: a novel anti\u2010obesity drug. A review of the pharmacological evidence to differentiate it from d\u2010amphetamine and d\u2010fenfluramine","volume":"22","author":"Heal DJ","year":"1998","journal-title":"Int J Obes"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(88)90003-6"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01423-1"},{"issue":"3","key":"e_1_2_5_5_2","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21","author":"Guerciolini R","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801481"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.07.005"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802850"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2003.188"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00701.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00481.x"},{"key":"e_1_2_5_12_2","first-page":"156","article-title":"Initial weight loss as predictor of long term weight loss with sibutramine","volume":"20","author":"Heath MJ","year":"1996","journal-title":"Int J Obes"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802591"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802165"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2005.00483.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01530.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D183"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(198605)5:4<747::AID-EAT2260050413>3.0.CO;2-6"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1037\/0278-6133.26.1.105"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-108X(200101)29:1<85::AID-EAT14>3.0.CO;2-G"},{"key":"e_1_2_5_21_2","volume-title":"Professional Manual","author":"Costa PT","year":"1992"},{"key":"e_1_2_5_22_2","volume-title":"Structured Personality Learning Theory","author":"Catell RB","year":"1983"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-3514.54.5.853"},{"key":"e_1_2_5_24_2","volume-title":"Statistical Power Analysis for the Behaviour Sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/eat.2260150411"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2007.00740.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2007.00740.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:03:44Z","timestamp":1761887024000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2007.00740.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,26]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1463-1326.2007.00740.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2007.00740.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,26]]}}}